Pes, Lara <br/><br/>
Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound.  [electronic resource] 

 -  Journal of controlled release : official journal of the Controlled Release Society  02 2019 
 - 81-92 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-4995 
<br/><br/><label>Standard No.: </label>10.1016/j.jconrel.2019.01.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminobenzoates--administration & dosage<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Cell Line, Tumor<br/>Drug Liberation<br/>Female<br/>Humans<br/>Hydrogen-Ion Concentration<br/>Mice, Nude<br/>Models, Molecular<br/>Neoplasms--drug therapy<br/>Oligopeptides--administration & dosage<br/>Prodrugs--administration & dosage<br/>Rats, Sprague-Dawley<br/>Serum Albumin--metabolism<br/>Xenograft Model Antitumor Assays